Total synthesis and stereochemical reassignment of (+)-neopeltolide

Angewandte Chemie - International Edition

Volumn 46, Issue 48, 2007, Pages 9211-9214

  Youngsaye, Willmen ^a   Lowe, Jason T ^a   Pohlki, Frauke ^a   Ralifo, Paul ^a   Panek, James S ^a  

^a Boston University   (United States)

Author keywords

Annulation; Antitumor agents; Macrolides; Natural products; Total synthesis

Indexed keywords

ANTITUMOR AGENTS; MACROLIDES; NATURAL PRODUCTS; TOTAL SYNTHESIS;

ENANTIOSELECTIVITY; OLEFINS; SYNTHESIS (CHEMICAL);

STEREOCHEMISTRY;

MACROLIDE; NEOPELTOLIDE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHEMISTRY; METABOLISM; SPONGE (PORIFERA); STEREOISOMERISM; SYNTHESIS;

ANIMALS; MACROLIDES; PORIFERA; STEREOISOMERISM;

EID: 37349010312     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200704122     Document Type: Article

References (44)

1. a) A. E. Wright, J. C. Botelho, E. Guzmán, D. Harmody, P. Linley, P. J. McCarthy, T. P. Pitts, S. A. Pomponi, J. K. Reed, J. Nat. Prod. 2007, 70, 412-416;
2. b) A. E. Wright, S. A. Pomponi, P. J. McCarthy, US Patent 7179828B2, 2007.
3. a) M. V. D'Auria, A. Zampella, L. Gomez-Paloma, L. Minale, C. Debitus, C. Roussakis, V. Le Bert, Tetrahedron 1996, 52, 9589-9596;
4. b) A. Zampella, M. V. D'Auria, L. G. Paloma, A. Casapullo, L. Minale, C. Debitus, Y. Henin, J. Am. Chem. Soc. 1996, 118, 6202-6209;
5. c) A. Zampella, M. V. D'Auria, L. Minale, C. Debitus, C. Roussakis, J. Am. Chem. Soc. 1996, 118, 11085-11088.
6. L. T. Tan, B. L. Márquez, W. H. Gerwick, J. Nat. Prod. 2002, 65, 925-928.
7. M. D'Ambrosio, A. Guerriero, C. Debitus, F. Pietra, Helv. Chim. Acta 1996, 79, 51-60.
8. For total syntheses of leucascandrolide A, see a) K. R. Hornberger, C. L. Hamblett, J. L. Leighton, J. Am. Chem. Soc. 2000, 122, 12894-12895;
9. b) Y. Wang, J. Janjic, S. A. Kozmin, J. Am. Chem. Soc. 2002, 124, 13670-13671;
10. c) A. Fettes, E. M. Carreira, Angew. Chem. 2002, 114, 4272-4275;
11. Angew. Chem. Int. Ed. 2002, 41, 4098-4101;
12. d) I. Paterson, M. Tudge, Angew. Chem. 2003, 115, 357-361;
13. Angew. Chem. Int. Ed. 2003, 42, 343-347;
14. e) A. Fettes, E. M. Carreira, J. Org. Chem. 2003, 68, 9274-9283;
15. f) I. Paterson, M. Tudge, Tetrahedron 2003, 59, 6833-6849;
16. g) Y. Wang, J. Janjic, S. A. Kozmin, Pure Appl. Chem. 2005, 77, 1161-1169;
17. h) Q. Su, L. A. Dakin, J. S. Panek, J. Org. Chem. 2007, 72, 2-24;
18. i) L. J. Van Orden, B. D. Patterson, S. D. Rychnovsky, J. Org. Chem. 2007, 72, 5784-5793.
19. For syntheses of the leucascandrolide A macrolide, see j) D. J. Kopecky, S. D. Rychnovsky, J. Am. Chem. Soc. 2001, 123, 8420-8421;
20. k) P. Wipf, J. T. Reeves, Chem. Commun. 2002, 2066-2067;
21. l) D. R. Williams, S. V. Plummer, S. Patnaik, Angew. Chem. 2003, 115, 4064-4068;
22. Angew. Chem. Int. Ed. 2003, 42, 3934-3938;
23. m) D. R. Williams, S. Patnaik, S. V. Plummer, Org. Lett. 2003, 5, 5035-5038;
24. n) M. T. Crimmins, P. Siliphaivanh, Org. Lett. 2003, 5, 4641-4644;
25. o) L. Ferrié, S. Reymond, P. Capdevielle, J. Cossy, Org. Lett. 2007, 9, 2461-2464.
26. Other reports of leucascandrolide A fragments include: p) M. T. Crimmins, C. A. Carroll, B. W. King, Org. Lett. 2000, 2, 597-599;
27. q) S. A. Kozmin, Org. Lett. 2001, 3, 755-758;
28. r) L. A. Dakin, N. F. Langille, J. S. Panek, J. Org. Chem. 2002, 67, 6812-6815;
29. s) P. Wipf, T. H. Graham, J. Org. Chem. 2001, 66, 3242-3245.
30. 13C NMR spectra of these compounds, see the Supporting Information. These spectroscopic differences, along with identical mass spectroscopy data and fragmentation patterns for both samples, suggested a possible misassignment (data were kindly provided by Dr A. E. Wright).
31. Compound 7 was synthesized in the same way as its enantiomer, see N. Holub, J. Neidhofer, S. Blechert, Org. Lett. 2005, 7, 1227-1229.
32. Methyl (R)-(+)-3-methylglutarate is available from Sigma-Aldrich Co. (Catalog number 380466). Alternatively, it can be prepared through enzymatic desymmetrization of racemic dimethyl 3-methylglutarate with porcine liver esterase, see L. K. P. Lam, R. A. H. F. Hui, J. B. Jones, J. Org. Chem. 1986, 51, 2047-2050.
33. P. Herold, P. Mohr, C. Tamm, Helv. Chim. Acta 1983, 66, 744-754.
34. a) D. A. Evans, A. H. Hoveyda, J. Am. Chem. Soc. 1990, 112, 6447-6449;
35. b) C. Schneider, K. Klapa, M. Hansch, Synlett 2005, 91-94;
36. c) T. E. La Cruz, S. D. Rychnovsky, J. Org. Chem. 2007, 72, 2602-2611.
37. 13C NMR spectroscopic analysis of the acetonide derived from the diol product obtained after DIBAL-H reduction of the C13 acyl protecting group. S. D. Rychnovsky, B. Rogers, G. Yang, J. Org. Chem. 1993, 58, 3511-3515.
38. H. Meerwein, Org. Synth. 1973, Coll. Vol. 5, 1080.
39. a) K. Omura, D. Swern, Tetrahedron 1978, 34, 1651-1660;
40. b) S. L. Huang, K. Omura, D. Swern, D. Further, Synthesis 1978, 297-299.
41. B. S. Bal, W. E. Childers, Jr., H. W. Pinnick, Tetrahedron 1981, 37, 2091-2096.
42. For preparation of the phosphonoacetic acid, see S. Sano, Y. Takemoto, Y. Nagao, Tetrahedron Lett. 2003, 44, 8853-8855, and references therein.
43. 13C NMR spectra of 1b and 1a, see the Supporting Information.
44. Starting from commercially available methyl (R)-(+)-3- methylglutarate 9.